Savara to Present at the Inaugural Piper Sandler Lung Day

Rhea-AI Summary

Savara, a clinical stage biopharmaceutical company, announced its participation in a Fireside Chat at the inaugural Piper Sandler Lung Day on October 15, 2021, at 10:30 am ET. This event will discuss their lead program, molgramostim nebulizer solution, which is in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Following the event, a replay will be available on Savara’s website for 90 days.

AUSTIN, Texas--(BUSINESS WIRE)-- Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a Fireside Chat at the Inaugural Piper Sandler Lung Day on Friday, October 15, 2021 at 10:30 am ET / 7:30 am PT.

Following the event, a replay of the webcast will be available through the Investors page of Savara’s website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days.

About Savara

Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.

More information can be found at www.savarapharma.com. (Twitter: @SavaraPharma, LinkedIn: www.linkedin.com/company/savara-pharmaceuticals/).

View source version on businesswire.com: https://www.businesswire.com/news/home/20211007005116/en/

Savara Inc. IR & PR

Anne Erickson

Senior Vice President, Chief of Staff

anne.erickson@savarapharma.com

(512) 851-1366

Source: Savara Inc.

FAQ

When is Savara Inc.'s Fireside Chat at Piper Sandler Lung Day?

Savara Inc. will participate in the Fireside Chat on October 15, 2021, at 10:30 am ET.

What is the main focus of Savara Inc. during the Piper Sandler Lung Day?

Savara will focus on its lead program, molgramostim nebulizer solution, for autoimmune pulmonary alveolar proteinosis.

Where can I access the replay of Savara's presentation after the event?

The replay can be accessed on Savara’s investors page at www.savarapharma.com/investors/events-presentations/.